Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer

Menopause

Volumn 12, Issue 4, 2005, Pages 436-443

  Conde, Délio M ^a   Pinto Neto, Aarão M ^a   Cabello, César ^a   Sá, Danielle S ^a   Costa Paiva, Lúcia ^a   Martinez, Edson Z ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; Climacteric syndrome; Menopause; Quality of life; SF 36 questionnaire

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CLIMACTERIUM; FEMALE; HORMONAL THERAPY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OUTCOMES RESEARCH; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL BEHAVIOR; SHORT FORM 36;

AGED; BRAZIL; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HOT FLASHES; HUMANS; LINEAR MODELS; MENOPAUSE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL BEHAVIOR;

EID: 23244443122     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000151655.10243.48     Document Type: Article

References (53)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-S66.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
3. National Cancer Institute. Surveillance, Epidemiology and End Results. Available at: http://www.seer.cancer.gov/csr/1975_2001/results_merged/ sect_04_breast.pdf. Accessed August 10, 2004.
4. Instituto Nacional de Câncer (National Institute of Cancer)-Brasil. Incidence of cancer estimate in Brazil 2003. Available at: http://www.inca.gov. br/estimativas/2003/versaofinal.pdf. Accessed May 11, 2004.
5. Fundação Oncocentro de São Paulo-Brasil. Distribution of malignant neoplasms of the female breast according to age range. Available at: http://www.fosp.saude.sp.gov.br/html/at_mama.html. Accessed May 11, 2004.
6. Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 1998;51:1271-1276.
7. Pedro AO, Pinto-Neto AM, Costa-Paiva LHS, Osis MJ, Hardy E. Age at natural menopause among Brazilian women: results from a population-based survey. Cad Saude Publica 2003;19:17-25.
8. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 2000;92:1054-1064.
9. Couzi RJ, Helzlsouer KJ, Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737-2744.
10. Carpenter JS, Andrykowski MA, Cordova M, et al. Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 1998;82:1682-1691.
11. Fisher B, Constantino JP, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989;320:479-484.
12. Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388.
13. Greene JG. The cross-sectional legacy: an introduction to longitudinal studies of the climacteric. Maturitas 1992;14:95-101.
14. Schwingl PJ, Hulka BS, Harlow SD. Risk factors for menopausal hot Hashes. Obstet Gynecol 1994;84:29-34.
15. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356.
16. Stein KD, Jacobsen PB, Hann DM, Greenberg H, Lyman G. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage 2000;19:436-445.
17. Carpenter JS, Johnson DH, Wagner LJ, Andrykowski MA. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29:16-25.
18. Ganz PA, Day R, Ware JE, Redmond C, Fisher B. Baseline quality of life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995;87:1372-1382.
19. Dow KH, Ferrell BR, Leigh S, Ly J, Gulasekaram P. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 1996;39:261-273.
20. Jamison KR, Wellisch DK, Pasnau RO. Psychosocial aspects of mastectomy: I. The women's perspective. Am J Psychiatry 1978;135:432-436.
21. Peters-Golden H. Breast cancer: varied perceptions of social support in the illness experience. Soc Sci Med 1982;16:483-491.
22. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94:39-49.
23. Mor V, Malin M, Allen S. Age differences in the psychosocial problems encountered by breast cancer patients. J Natl Cancer Inst Monogr 1994;65:191-197.
24. Kornblith AB, Herndon JE 2nd, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003;98:679-689.
25. Fleiss JL. Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley and Sons, 1981.
26. Pedro AO, Pinto-Neto AM, Costa-Paiva LHS, Osis MJD, Hardy EE. Climacteric syndrome: a population-based study in Brazil. Rev Saude Publica 2003;37:735-742.
27. Brambilla DJ, McKinklay SM, Johannes CB. Defining the perimenopause for applications in epidemiological investigations. Am J Epidemiol 1994;140:1091-1095.
28. Utian W. Consensus Workshop: the climacteric syndrome. In: Van Keep, ed. Consensus on Menopause Research. Lancaster: MTP, 1976.
29. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
30. Wood-Dauphinee S. Assessing quality of life in clinical research: from where have we come and where are we going. J Clin Epidemiol 1999;52:355-363.
31. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol 1999;39:143-150.
32. Ware JE Jr, Snow KK, Kosinski M, Gardek B. The SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: Quality Metric Incorporated; 2000.
33. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall; 1990.
34. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989.
35. Koenker R, Bassett G. Regression quantiles. Econometrica 1978;46:33-50.
36. StataCorp. 1999. Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation.
37. Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 1993;168:772-780.
38. Biglia N, Cozzarella M, Cacciari F, et al Menopause after breast cancer: a survey on breast cancer survivors. Maturitas 2003;45:29-38.
39. Martin MC, Block JE, Sanchez SD, Arnaud CD, Beyene Y. Menopause without symptoms: the endocrinology of menopause among rural Mayan Indians. Am J Obstet Gynecol 1993;168:1839-1845.
40. Beyene Y. The cultural significance and physiological manisfestation of menopause: a bicocultural analysis. Cult Med Psychiatry 1986;10:47-71.
41. Lock M. Menopause: lessons from anthropology. Psychosom Med 1998;60:410-419.
42. Arnold BJ, Cumming CE, Lees AW, Handman MD, Cumming DC, Urion C. Tamoxifen in breast cancer: symptom reporting. Breast J 2001;7:97-100.
43. Love RR, Cameron L, Connell BL, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991;151:1842-1847.
44. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 2002;23:501-509.
45. Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol 2003;30:799-813.
46. Holte A, Mikkelsen A. Psychosocial determinants of climacteric complaints. Maturitas 1991;13:205-215.
47. Dorval M, Maunsell E, Deschênes L, Brisson J, Mâsse B. Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol 1998;16:487-494.
48. Barni S, Mondin R. Sexual dysfunction in treated breast cancer patients. Ann Oncol 1997;8:149-153.
49. Utian WH, Schiff I. North American Menopause Society-Gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 1994;1:39-48.
50. Blümel JE, Castelo-Branco C, Cancelo MJ, Romero H, Aprikian D, Sarrá S. Impairment of sexual activity in middle-aged women in Chile. Menopause 2004;11:78-81.
51. Fukui S, Kugaya A, Okamura H, et al. A psychosocial group intervention for Japanese women with primary breast carcinoma. Cancer 2000;89:1026-1036.
52. Okamura H, Fukui S, Nagasaka Y, Koike M, Uchitomi Y. Psychoeducational intervention for patients with primary breast cancer and patient satisfaction with information: an exploratory analysis. Breast Cancer Res Treat 2003;80:331-338.
53. Arndt V, Merx H, Stürmer T, Stegmaier C, Ziegler H, Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer 2004;40:673-680.